17289-30-4 Usage
Uses
Used in Pharmaceutical Research and Development:
5-CHLOROMETHYL-1-METHYL-1H-IMIDAZOLE HCL is used as a reagent in the synthesis of various pharmaceuticals and agrochemicals, contributing to the development of new drugs and agricultural products.
Used in Antifungal and Antibacterial Applications:
5-CHLOROMETHYL-1-METHYL-1H-IMIDAZOLE HCL has been studied for its potential antifungal and antibacterial properties, making it a candidate for use in treatments and preventive measures against microbial infections.
Used in Chemical Manufacturing:
In the chemical industry, 5-CHLOROMETHYL-1-METHYL-1H-IMIDAZOLE HCL may be employed in the manufacturing of dyes and pigments, where its unique chemical structure can contribute to the creation of novel colorants and other specialty chemicals.
Used in Other Industrial Applications:
Beyond the pharmaceutical and chemical manufacturing sectors, 5-CHLOROMETHYL-1-METHYL-1H-IMIDAZOLE HCL may have additional industrial applications that leverage its chemical properties, although these are not detailed in the provided materials.
Check Digit Verification of cas no
The CAS Registry Mumber 17289-30-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,7,2,8 and 9 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 17289-30:
(7*1)+(6*7)+(5*2)+(4*8)+(3*9)+(2*3)+(1*0)=124
124 % 10 = 4
So 17289-30-4 is a valid CAS Registry Number.
17289-30-4Relevant academic research and scientific papers
ARYL SUBSTITUTED IMIDAZO [4,5-C] PYRIDINE COMPOUNDS AS C3A RECEPTOR ANTAGONISTS
-
Page/Page column 58, (2010/11/26)
Aryl substituted imidazo[4,5-c] pyridine compounds of formula (I) or pharmaceutically acceptable salt thereof are provided. These compounds are useful in pharmaceutical compositions as C3a antagonists for treating a variety of medical conditions associated with the Complement cascade.
2-PHENYLPYRIDIN-4-YL DERIVATIVES AS ALK5 INHIBITORS
-
Page 47, (2010/02/06)
This invention relates to novel 2-phenylpyridin-4-yl heterocyclyl derivatives which are inhibitors of the transforming growth factor, ("TGF")-? signalling pathway, in particular, the phosphorylation of smad2 or smad3 by the TGF-β type I or activin-like kinase ("ALK")-5 receptor, methods for their preparation and their use in medicine, specifically in the treatment and prevention of a disease state mediated by this pathway.
